Protein based TNF-alpha variants for the treatment of TNF-alpha related disorders

Details for Australian Patent Application No. 2004279895 (hide)

Owner Xencor, Inc.

Inventors Zalevsky, Jonathan; Desjarlais, John R.; Steed, Paul Michael; Szymkowski, David Edmund

Agent Davies Collison Cave

Pub. Number AU-A-2004279895

PCT Pub. Number WO2005/035564

Priority 60/510,430 10.10.03 US

Filing date 12 October 2004

Wipo publication date 21 April 2005

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 14/525 (2006.01) Peptides having more than 20 amino acids

Event Publications

25 May 2006 PCT application entered the National Phase

  PCT publication WO2005/035564 Priority application(s): WO2005/035564

27 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004279896-Energy converting device

2004279891-Sheet dividers with enhanced tabs